- Report
- November 2024
- 90 Pages
North America
From €3040EUR$3,450USD£2,670GBP
- Report
- November 2024
- 84 Pages
Middle East, Africa
From €3040EUR$3,450USD£2,670GBP
- Report
- November 2024
- 90 Pages
Europe
From €3040EUR$3,450USD£2,670GBP
- Report
- November 2024
- 93 Pages
Asia Pacific
From €3040EUR$3,450USD£2,670GBP
- Report
- May 2024
- 292 Pages
Global
From €4402EUR$4,995USD£3,866GBP
- Report
- October 2024
- 80 Pages
Global
From €8808EUR$9,995USD£7,736GBP
- Report
- January 2022
- 278 Pages
Global
From €3745EUR$4,250USD£3,290GBP
- Report
- July 2023
- 102 Pages
Global
From €3500EUR$4,255USD£3,182GBP
- Report
- December 2025
- 50 Pages
Global
From €2335EUR$2,650USD£2,051GBP
- Report
- December 2025
- 50 Pages
Global
From €2335EUR$2,650USD£2,051GBP
- Report
- December 2025
- 50 Pages
Global
From €2335EUR$2,650USD£2,051GBP
- Report
- November 2021
- 600 Pages
Global
From €3525EUR$4,000USD£3,096GBP

Morphine is an analgesic drug used to treat moderate to severe pain. It is a member of the opioid family, and is derived from the opium poppy plant. Morphine is available in a variety of forms, including tablets, capsules, syrups, and injectable solutions. Morphine is often used in the treatment of cancer pain, post-operative pain, and chronic pain. It is also used to treat acute pain, such as that caused by a heart attack or stroke. Morphine is generally considered to be a safe and effective analgesic, but it can cause side effects such as nausea, vomiting, constipation, and drowsiness.
Morphine is available in both generic and brand-name formulations. Some of the major companies in the market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more